Summary
ILiAD Biotechnologies LLC
Founded in 2012
Description
ILiAD is developing the leading next generation vaccine for the prevention of #WhoopingCough, a serious illness caused by Bordetella #pertussis.
Strengths
- Revenue growth is more steady than the industry average
- Since ILiAD Biotechnologies LLC was founded, the company has grown faster than the industry average
Weaknesses
- ILiAD Biotechnologies LLC has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
Annual Revenue
ILiAD Biotechnologies LLC's annual revenue
$4102000
Based on Kona Equity data
-
Revenue per employee
$315538
-
Variance of revenue growth
0.06
-
Annual revenue growth since founding
$341833
-
Revenue growth rate from first known quarter to current
-16.5%
Employee Count
13 employees
-
Employee growth rate from first known quarter to current
-11.5%
Executives
Ken Solovay
Chief Operating Officer
k**@iliadbio.comJim Ramadei
Controller
j**@iliadbio.comLuis Nogales
Executive Vice President & Chief Development Officer
l**@iliadbio.comStephanie Noviello
Chief Medical Officer
s**@iliadbio.comPeter Goldstein
Senior Director
p**@iliadbio.comKeith Rubin
CEO
k**@iliadbio.comMatthew Bross
Administrative Manager
m**@iliadbio.comSteve Glazer
Director, Research Programs
s**@iliadbio.comPhone Biotechnologies
Founder & Chief Executive Officer
p**@iliadbio.comAvi Naider
Board Member
a**@iliadbio.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: ILiAD Biotechnologies LLC
- Category: Biotechnology
- SIC: 283; 28
- NAICS: 5417; 541
See similar companies
-
By City New York City Biotechnology in New York City Small Biotechnology in New York City Mid-size Biotechnology in New York City
-
By State NY Small companies in NY Biotechnology in NY Small Biotechnology in NY Mid-size Biotechnology in NY
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology G Score of 2
-
Firmographic data G Score of 2 Founded in 2012 SIC: 283 SIC: 28 NAICS: 5417 NAICS: 541 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
ILiAD Biotechnologies LLC's headquarters are located at 230 East 15th St. Ste. 1-A New York City, NY 10003.
ILiAD Biotechnologies LLC's official website is iliadbio.com
ILiAD Biotechnologies LLC's annual revenue is $4.1 M.
ILiAD Biotechnologies LLC's SIC: 283; 28
ILiAD Biotechnologies LLC's NAICS: 5417; 541.
ILiAD Biotechnologies LLC has 13 employees
ILiAD Biotechnologies LLC is in the industry of Biotechnology.